z-logo
Premium
Structural characterization of novel chemotactic and mastoparan peptides from the venom of the social wasp Agelaia pallipes pallipes by high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry
Author(s) -
Mendes Maria Anita,
Monson de Souza Bibiana,
Delazari dos Santos Lucilene,
Palma Mario Sergio
Publication year - 2004
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.1382
Subject(s) - chemistry , mastoparan , electrospray ionization , chromatography , venom , peptide , tandem mass spectrometry , mass spectrometry , high performance liquid chromatography , biochemistry , receptor , g protein
High‐performance liquid chromatography/electrospray ionization mass spectrometry (HPLC/ESI‐MS) and high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC‐ESI‐MS/MS) techniques were applied for the detection, purification, monitoring, and sequencing of two novel and biologically active peptides occurring at very low levels in the venom of the wasp Agelaia pallipes pallipes . These peptides were sequenced under LC/ESI‐MS/MS conditions and designated as Agelaia‐CP (I/L‐L‐G‐T‐I‐L‐G‐L‐L‐K‐G‐I/L‐NH 2 , MW 1207.8 Da) and Agelaia‐MP (I/L‐N‐W‐L‐K‐L‐G‐K‐A‐I‐I‐D‐A‐I/L‐NH 2 , MW 1565.0 Da). The peptide Agelaia‐CP showed no hemolytic activity, but it behaved as a mast cell degranulator and induced a potent chemotaxis in polymorphonucleated leukocyte (PMNL) cells, typical of a wasp chemotactic peptide. The peptide Agelaia‐MP showed both powerful mast cell degranulation and hemolysis of washed rat red blood cells, and is thus assigned as a new member of the mastoparan family of peptides. Both peptides seem to be directly involved in the strong inflammatory reactions associated with wasp stings. Copyright © 2004 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here